Semaglutide Significantly Improves MASH Resolution, but Fibrosis Benefits Remain Limited: Study

Pakistan: A study published in Medicine has found that semaglutide was associated with more than twice the likelihood of resolving metabolic dysfunction-associated steatohepatitis (MASH) compared with...